William Colyer, MD
Interventional Cardiology · Toledo, OHNPI 1679567119
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $121,766 of the $138,835 with a category attached, or 87.7%. 41 manufacturers reported payments, led by Boehringer Ingelheim at 59.6% of the total. Reporting peaked in 2019 at $77,046 and has fallen 98.7% since, to $1,014 in 2025. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 409 payments — averaging $339.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$83K
- Novartis$24K
- Lilly USA, LLC$22K
- Daiichi Sankyo Inc.$4K
- Boston Scientific$2K
- Shockwave Medical, Inc$584
- plus $4K from 35 others
What the payments were for
- Consulting fees$4,7503%
- Speaking & faculty fees$121,76688%
- Travel & lodging$2,9522%
- Food & beverage$9,3407%
- Education$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 83 | $82,772 |
| Novartis | 62 | $24,494 |
| Lilly USA, LLC | 36 | $22,141 |
| Daiichi Sankyo Inc. | 6 | $3,553 |
| Boston Scientific | 23 | $1,756 |
| Shockwave Medical, Inc | 8 | $584 |
| AstraZeneca(2 entities) | 31 | $545 |
| Johnson & Johnson | 24 | $353 |
| Amgen | 16 | $253 |
| Abbott | 9 | $207 |
| Abiomed | 9 | $206 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $204 |
| Biotronik Inc. | 2 | $173 |
| Amarin Pharma, Inc. | 10 | $150 |
| United Therapeutics Corporation | 8 | $149 |
| Pfizer | 10 | $125 |
| Philips North America LLC | 5 | $114 |
| E.r. Squibb & Sons, L.L.C. | 7 | $105 |
| Teleflex LLC | 1 | $98 |
| Sanofi-aventis U.S. LLC | 6 | $84 |
| Medtronic | 4 | $82 |
| Scpharmaceuticals Inc. | 3 | $70 |
| Bayer | 3 | $63 |
| Merck | 4 | $63 |
| Lundbeck LLC | 4 | $62 |
| Inari Medical, Inc. | 3 | $58 |
| Atricure, Inc. | 1 | $57 |
| Regeneron Healthcare Solutions, Inc. | 4 | $52 |
| Chiesi USA, Inc. | 2 | $49 |
| Edwards Lifesciences | 1 | $25 |
| Lexicon Pharmaceuticals, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Heartflow, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Gilead | 1 | $16 |
| GE HealthCare | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Bard Peripheral Vascular, Inc. | 1 | $11 |
| Cardiovascular Systems Inc. | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$102,568
- ENTRESTO$23,460
- INJECTAFER$3,485
- AVVIGO Guidance System$375
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$364
- GENERAL - THERAPIES$252
- ReCross$159
- CROSSBOSS$140
- SYNERGY$133
- LEQVIO$124
- GENERAL - STENTS$122
- MAMBA$121
- BRILINTA$110
- WOLVERINE$110
- EMBLEM MRI S-ICD$108
How this compares
$138,835 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 149 | $188,094 |
| EliquisApixaban | 134 | $160,642 |
| EntrestoSacubitril/Valsartan | 46 | $65,781 |
| Repatha SureclickEvolocumab | 88 | $53,686 |
| XareltoRivaroxaban | 30 | $21,402 |
| BrilintaTicagrelor | 16 | $13,502 |
| Praluent PenAlirocumab | 16 | $11,869 |
| NexletolBempedoic Acid | 12 | $5,545 |
| Ezetimibe | 211 | $5,420 |
| Atorvastatin Calcium | 278 | $3,779 |
| Ranolazine ErRanolazine | 36 | $3,314 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $2,911 |
| Metoprolol Succinate | 177 | $2,493 |
| Rosuvastatin Calcium | 149 | $2,258 |
| Spironolactone | 192 | $1,741 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $82,772 | $188,094149 claims |
| PfizerEliquis | $125 | $160,642134 claims |
| NovartisEntresto | $24,494 | $65,78146 claims |
| Johnson & JohnsonXarelto | $353 | $21,40230 claims |
| AstraZenecaBrilinta | $545 | $13,50216 claims |
| Esperion Therapeutics, Inc.Nexletol | $13 | $5,54512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Toledo
- P Kasi RamanathanToledo$101K
- Stephanie YounesToledo$49K
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.